Variant report
Variant | nsv159319 |
---|---|
Chromosome Location | chr1:103645616-103655285 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566620774 | chr1:103645629-103645630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370501310 | chr1:103645637-103645638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114711808 | chr1:103645680-103645681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552053482 | chr1:103645696-103645697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139863308 | chr1:103645784-103645785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78769305 | chr1:103645825-103645826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537434096 | chr1:103645837-103645838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11288016 | chr1:103645854-103645855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529176457 | chr1:103645861-103645862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142547422 | chr1:103645893-103645894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144791168 | chr1:103645962-103645963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535496836 | chr1:103646007-103646008 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76852025 | chr1:103646012-103646013 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572553560 | chr1:103646038-103646039 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147963524 | chr1:103646047-103646048 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564760492 | chr1:103646084-103646085 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182439637 | chr1:103646085-103646086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188053953 | chr1:103646172-103646173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114921336 | chr1:103646233-103646234 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141890011 | chr1:103646234-103646235 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6674625 | chr1:103646247-103646248 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs547825753 | chr1:103646257-103646258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560139000 | chr1:103646284-103646285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527476154 | chr1:103646296-103646297 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112421584 | chr1:103646305-103646306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192566346 | chr1:103646307-103646308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570389785 | chr1:103646312-103646313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs114595455 | chr1:103646324-103646325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs56335123 | chr1:103646356-103646357 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs150479345 | chr1:103646385-103646386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184371394 | chr1:103646505-103646506 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548279755 | chr1:103646506-103646507 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566589053 | chr1:103646521-103646522 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549525017 | chr1:103646539-103646540 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs56739111 | chr1:103646542-103646543 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs535035682 | chr1:103646553-103646554 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549013078 | chr1:103646574-103646575 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540022145 | chr1:103646585-103646586 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558355931 | chr1:103646693-103646694 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115431015 | chr1:103646698-103646699 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552207491 | chr1:103646725-103646726 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544053918 | chr1:103646789-103646790 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371163083 | chr1:103646825-103646826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145218717 | chr1:103646831-103646832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7528984 | chr1:103646849-103646850 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs541210260 | chr1:103646884-103646885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149125487 | chr1:103646911-103646912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs60949157 | chr1:103646919-103646920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs67504438 | chr1:103646921-103646922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs68137445 | chr1:103646922-103646923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:103637200-103646000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr1:103644000-103646200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr1:103644400-103646400 | Weak transcription | A549 | lung |
4 | chr1:103646000-103646600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr1:103646000-103647200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr1:103646000-103647200 | Enhancers | HSMM | muscle |
7 | chr1:103646000-103647200 | Enhancers | NH-A | brain |
8 | chr1:103646000-103647400 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr1:103646000-103647400 | Enhancers | Fetal Heart | heart |
10 | chr1:103646200-103646600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr1:103646200-103646600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr1:103646200-103646600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr1:103646200-103646600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr1:103646200-103646600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr1:103646200-103646600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr1:103646400-103646800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
17 | chr1:103646400-103646800 | Active TSS | A549 | lung |
18 | chr1:103646800-103647200 | Enhancers | A549 | lung |
19 | chr1:103647200-103659400 | Weak transcription | HSMM | muscle |
20 | chr1:103647400-103647600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr1:103654800-103656400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |